Search clinical trials for: Pola-R-DHAP

Total 3897 results

Fondazione Italiana Linfomi - ETS
Roche Pharma AG

Withdrawn

R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma (FIL_POLARDHAP)

Diffuse Large B-cell Lymphoma Recurrent | Diffuse Large B Cell Lymphoma Refractory

Italy
Sun Yat-sen University

Not yet recruiting

Lisatoclax Plus R-CHOP or Pola-R-CHP in Untreated DLBCL: A Phase Ib/II Study

Diffuse Large B Cell Lymphoma (DLBCL)

China
Fudan University

Recruiting

Study on Predicting Response to Standard First-Line Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Using ctDNA Combined With PET

Diffuse Large B-Cell Lymphoma | DLBCL

China
Fondazione Italiana Linfomi ONLUS

Recruiting

Phase II of High-dose Therapy in Elderly Patients With Relapsed Aggressive NHL or Resistant to First Line Therapy

Non Hodgkin Lymphoma

Italy
The First Affiliated Hospital with Nanjing Medical...

Recruiting

Efficacy and Safety of Polatuzumab Vedotin in Combination With Zanubrutinib, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma of the MCD/BN2/N1 Subtypes (Pola-ZRCHP)

Diffuse Large B-Cell Lymphoma (DLBCL)

China

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe